Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcome

Jeffrey A. Sosman*, Joseph M. Unger, P. Y. Liu, Lawrence E. Flaherty, Min S. Park, Raymond A. Kempf, John A. Thompson, Paul I. Terasaki, Vernon K. Sondak

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

183 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcome'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences

Immunology and Microbiology